The UK Labour Party Document, “Medicines-For-The-Many” is 52 pages long, including 9 pages of end notes. It is an ambitious document. The document discusses, in some detail, innovation as well as access and affordability. The reforms proposed include measures that… Continue Reading →
Today, in his address to the U.K. Labour party conference, Labour Leader Jeremy Corbyn made the following statement on drug patents and prices. Yesterday I met Luis Walker, a wonderful nine-year-old boy. Luis is living with cystic fibrosis. Every day… Continue Reading →
KEI filed this today, regarding a Federal Register request for comments (83 FR 57790) on the negotiating objectives for a U.S./UK trade agreement. KEI-US-UK-15Jan2019-statement-request2testify
EU For an earlier survey, see: 2014:1 KEI Research Note: Recent European Union Compulsory Licenses. 2014-03-01 DG-Enterprise – data exclusivity prevents access to life saving drugs (in the EU), even in an emergency situation, 2012-07-31 Germany German Court Issues Compulsory… Continue Reading →
Press Release: Coalition for Affordable T-DM1 Asks the UK Government to Employ Crown Use Authority to Lower Price of Expensive Cancer Drug sold by Roche
CONTACT:
Diarmaid McDonald
email: accessdiarmaid@gmail.com
+44.7894.4557.81
Susannah Markandya
email: s.markandya@gmail.com
+44.7811.9573.12
Zack Struver
email: zack.struver@keionline.org
Cell: +1.914.582.1428
Office: +1.202.332.2670 (between 2:00 PM and 10:00 PM BST)
Continue Reading →